REGENCELL BIOSCIENCE HLDGS L
RGC·G7487R100·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
RGC (REGENCELL BIOSCIENCE HLDGS L) is held by 26 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($2.6M), Alyeska Investment Group, L.P. ($2.5M), Legal & General Group Plc ($778,974). Net institutional sentiment: Mixed.
26
Holders
(1 Elite)
$8.4M
Total Value
63% (32)
Consensus
20 buying - 12 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders none · Activists Jul 11, 2025 · Congress none
ActivistR(Regencell (BVI) Limited86.2%Jul 11, 2025
Top Holders
Checking access…
Showing 1-20 of 33
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer